Narrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective

摘要: The advent of new antiretroviral medicines means that the effects HIV can now be curbed, but only one in twenty infected people have so far benefited. For those living developing countries, treatments are practically unattainable. Governments, UNAIDS and pharmaceutical companies recognise this too well rethought established assumption order to try overcome challenges posed by cost, inadequate health services unreliable local supply medicines.